| Autor: |
A. K. Yakovlev, L. A. Gayderova, N. A. Alpatova, T. N. Lobanova, E. L. Postnova, E. I. Yurchikova, T. A. Batuashvili, R. A. Volkova, V. N. Podkuiko, Yu. V. Olefir |
| Jazyk: |
ruština |
| Rok vydání: |
2017 |
| Předmět: |
|
| Zdroj: |
Standartnye Obrazcy, Vol 0, Iss 1, Pp 8-20 (2017) |
| Druh dokumentu: |
article |
| ISSN: |
2077-1177 |
| DOI: |
10.20915/2077-1177-2016-0-1-8-20 |
| Popis: |
Analysis of the publications devoted to the structure, functions, mechanism of action of erythropoietin is given in the article. Erythropoietin preparations derived from recombinant DNA technology are a mixture of isoforms with different biological activity, which determine the biological properties pharmacological activity, pharmacokinetics, efficacy and safety of medicinal product. Erythropoietin preparations derived by using recombinant DNA technology are a mixture of isoforms with different biological activity, that determine the biological properties, pharmacological activity, pharmacokinetics, safety and therapeutic efficacy of the drug. However, at production of erythropoietin, its pharmacological activity is controlled only by the ability to stimulate erythropoiesis, despite the multiplicity of different directions of action of drugs erythropoietin. The drug is dispensed and applied on this indicator. The international reference standard, a European reference biologic drug or calibrated by him enterprise standard samples are used by manufacturers to assess the quality of erythropoietin in the Russian Federation. The urgency of developing domestic standard samples for the evaluation of biological activity and physico-chemical characteristics of erythropoietin preparations produced by recombinant DNA technology. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
